Also trades as: APLLTD.NS (NSE) · $vol 1M
APLLTD.BO BSE
Alembic Pharmaceuticals Limited
1W: -5.2%
1M: -1.9%
3M: -2.5%
YTD: -6.5%
1Y: -15.6%
3Y: +55.0%
5Y: -17.1%
₹755.95 ($7.90)
+8.30 (+1.11%)
Weekly Expected Move ±4.2%
₹714
₹747
₹780
₹813
₹845
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹148.5B ($1.6B)
52W Range635.3-1107.8
Volume6,847
Avg Volume6,473
Beta0.88
Dividend₹11.00
Analyst Ratings
No analyst coverage
Company Info
CEOChirayu Ramanbhai Amin
Employees14,858
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2011-09-20
Websitealembicpharmaceuticals.com
Alembic Road
Vadodara 390003
IN
Vadodara 390003
IN
91 26 5663 7000
About Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.
Latest News
No recent news
Recent Insider Trades
No insider trades found